Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVIENT CORPAVNT · Entity 4061 | Director | September 30, 2026 | October 02, 2026 |
| COLGATE PALMOLIVE COCL · Entity 2972 | SVP, Global Technology | November 07, 2022 | November 09, 2022 |
| FMC CORPFMC · Entity 4704 | Director | July 16, 2026 | July 17, 2026 |
| Ingredion IncINGR · Entity 3745 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVIENT CORP
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,376 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 958 · Balance 29,376 |
COLGATE PALMOLIVE CO
Report date November 07, 2022 · Filed November 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Issuer's 401(k) Plan Trustee | 7,438 |
Reported balance
After 2022-11-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-11-07 · Other · Disposed 1,610 · Balance 7,438 F1: Transfer of funds within the issuer's 401(k) plan from Company stock to another investment option. |
| Common StockSEC Table I · non-derivative | Direct | 60,347 |
Reported balance
Holding disclosure · report date 2022-11-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 60,347 |
Filing footnotes · ownership attribution and instrument terms
F1: Transfer of funds within the issuer's 401(k) plan from Company stock to another investment option.
FMC CORP
Report date July 16, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,376 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 50 · Balance 16,376 F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.
Ingredion Inc
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,620 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,797 · Balance 5,620 F1: These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan to the Company's outside directors as part of their annual retainer (as further described in Exhibit 10.26 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 17, 2026). One portion of this grant covers the period from April 1, 2026 to May 19, 2026, and the remaining portion represents the full value of the outside directors' 2026 annual equity retainer, reflecting the Company's shift in 2026 from a calendar-year basis for director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on May 19, 2027, subject to the Committee's discretion to accelerate vesting upon an outside director's retirement, death, disability, or a Change in Control. |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan to the Company's outside directors as part of their annual retainer (as further described in Exhibit 10.26 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 17, 2026). One portion of this grant covers the period from April 1, 2026 to May 19, 2026, and the remaining portion represents the full value of the outside directors' 2026 annual equity retainer, reflecting the Company's shift in 2026 from a calendar-year basis for director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on May 19, 2027, subject to the Committee's discretion to accelerate vesting upon an outside director's retirement, death, disability, or a Change in Control.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MONSANTO CO /NEW/
Report date June 07, 2018 · Filed June 07, 2018
Section 16 reporting ended · disclosed 2018-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 1
1 source rowRow 1 · 2018-06-07 · Disposition to issuer · Disposed 2,832 · Balance 0 F3: Represents shares of restricted stock granted under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Deferred Payment Plan Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-06-07 · Disposition to issuer · Disposed 4,954 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").
F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
F3: Represents shares of restricted stock granted under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2022 Filed Feb 22, 2022 21:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 6,306 | $79.28 | $499,913.19 |
DisclosureSEC source: 0001225208-22-002888 · doc4.xml · nonDerivative · entry 2 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,246 F2 · kind: Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $79.11 to $79.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 21:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 12,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002888 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,552 F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:43 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 51,194 | $0.00 Strike: $72.99 | $0.00 |
DisclosureSEC source: 0001225208-22-001510 · doc4.xml · derivative · entry 4 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,194 shares Expires 2022-09-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:43 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 51,194 | $82.39 | $4,217,929.97 |
DisclosureSEC source: 0001225208-22-001510 · doc4.xml · nonDerivative · entry 2 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,053 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $82.17 to $82.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:43 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 51,194 | $72.99 | $3,736,650.06 |
DisclosureSEC source: 0001225208-22-001510 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 18:01 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000030 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:45 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Tax withholdingCommon Stock | 205 | $77.76 | $15,940.80 |
DisclosureSEC source: 0001225208-21-014789 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,053 F1 · kind: Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:06 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026259 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,311 Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:27 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 51,405 | $0.00 Strike: $77.04 | $0.00 |
DisclosureSEC source: 0001225208-21-012361 · doc4.xml · derivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,405 Underlying: Common Stock · 51,405 shares Expires 2029-09-10 F1 · kind: Stock option award granted under the issuer's incentive compensation plan. F2 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 10, 2021 grant date. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 12:22 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020881 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,567 Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:12 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 46,566 | $0.00 Strike: $61.93 | $0.00 |
DisclosureSEC source: 0001225208-21-007752 · doc4.xml · derivative · entry 4 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,566 shares Expires 2021-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2015 grant date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:12 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 46,566 | $80.89 | $3,766,928.63 |
DisclosureSEC source: 0001225208-21-007752 · doc4.xml · nonDerivative · entry 2 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,114 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.54 to $81.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:12 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 46,566 | $61.93 | $2,883,832.38 |
DisclosureSEC source: 0001225208-21-007752 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:20 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012592 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,898 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:28 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 9 | $78.36 | $705.24 |
DisclosureSEC source: 0001225208-21-003336 · doc4.xml · nonDerivative · entry 3 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,114 F2 · kind: Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to the vesting of incremental dividend equivalent units earned in connection with the issuer's most recent dividend payment. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:28 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 4,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003336 · doc4.xml · nonDerivative · entry 2 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,123 F1 · kind: Restricted stock unit award granted under the issuer's incentive compensation plan. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:28 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 4,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003336 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,080 F1 · kind: Restricted stock unit award granted under the issuer's incentive compensation plan. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:22 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 1,513 | $77.16 | $116,749.43 |
DisclosureSEC source: 0001225208-21-003034 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,545 F1 · kind: Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 17:23 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 804 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000071 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,216 Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 18:19 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-025980 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,412 Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 21:10 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 46,155 | $0.00 Strike: $76.41 | $0.00 |
DisclosureSEC source: 0001225208-20-011499 · doc4.xml · derivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,155 Underlying: Common Stock · 46,155 shares Expires 2028-09-10 F1 · kind: Stock option award granted under the issuer's incentive compensation plan. F2 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 10, 2020 grant date. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:30 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 42,775 | $0.00 Strike: $64.00 | $0.00 |
DisclosureSEC source: 0001225208-20-010421 · doc4.xml · derivative · entry 4 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,775 shares Expires 2020-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2014 grant date. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:30 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 42,775 | $76.52 | $3,273,006.12 |
DisclosureSEC source: 0001225208-20-010421 · doc4.xml · nonDerivative · entry 2 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,025 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $76.33 to $76.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:30 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 42,775 | $64.00 | $2,737,600.00 |
DisclosureSEC source: 0001225208-20-010421 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 16:07 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020547 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,210 Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 22:46 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-012474 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,960 Read SEC document |
| February 23, 2020 Filed Feb 25, 2020 22:03 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Tax withholdingCommon Stock | 1,878 | $76.27 | $143,235.06 |
DisclosureSEC source: 0001225208-20-003473 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,005 F1 · kind: Payment of tax liability by withholding shares from restricted stock units vesting under the issuer's incentive compensation plan. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 14:36 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000320 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,255 Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 19:37 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-029365 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,376 Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:55 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 48,044 | $0.00 Strike: $72.29 | $0.00 |
DisclosureSEC source: 0001225208-19-012563 · doc4.xml · derivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,044 Underlying: Common Stock · 48,044 shares Expires 2027-09-12 F1 · kind: Stock option award granted under the issuer's incentive compensation plan. F2 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 12, 2019 grant date. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:47 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 44,572 | $0.00 Strike: $59.28 | $0.00 |
DisclosureSEC source: 0001225208-19-011464 · doc4.xml · derivative · entry 4 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,572 shares Expires 2019-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2013 grant date. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:47 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 44,572 | $71.01 | $3,164,932.92 |
DisclosureSEC source: 0001225208-19-011464 · doc4.xml · nonDerivative · entry 2 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,724 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $70.695 to $71.260, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:47 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 44,572 | $59.28 | $2,642,228.16 |
DisclosureSEC source: 0001225208-19-011464 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 13:37 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023327 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375 Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 20:05 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-014109 · form4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:02 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 2,218 | $66.38 | $147,230.84 |
DisclosureSEC source: 0001123292-19-000315 · edgar.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,671 F1 · kind: Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 21:38 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Tax withholdingCommon Stock | 137 | $63.23 | $8,662.51 |
DisclosureSEC source: 0001225208-18-016390 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,805 F1 · kind: Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 20:40 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 43,323 | $0.00 Strike: $68.16 | $0.00 |
DisclosureSEC source: 0001225208-18-013486 · doc4.xml · derivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,323 Underlying: Common Stock · 43,323 shares Expires 2024-09-13 F1 · kind: Stock option award granted under the issuer's incentive compensation plan. F2 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 13, 2018 grant date. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:07 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 46,500 | $0.00 Strike: $52.27 | $0.00 |
DisclosureSEC source: 0001225208-18-012271 · doc4.xml · derivative · entry 4 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,500 shares Expires 2018-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's employee stock option plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2012 grant date. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:07 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 46,500 | $65.88 | $3,063,206.10 |
DisclosureSEC source: 0001225208-18-012271 · doc4.xml · nonDerivative · entry 2 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,766 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's employee stock option plan and the related tax withholding. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $65.82 to $65.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:07 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 46,500 | $52.27 | $2,430,555.00 |
DisclosureSEC source: 0001225208-18-012271 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's employee stock option plan. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:02 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerDeferred Payment Plan Restricted Stock Unit · Derivative | 4,954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015497 · doc4.xml · derivative · entry 2 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,954 shares Expires not disclosed F1 · derivative.exercise_price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.exercise_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.expiration_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.expiration_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:02 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 2,832 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015497 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: Represents shares of restricted stock granted under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:25 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-18-000063 · edgar.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,786 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 1,572 | $70.17 | $110,309.60 |
DisclosureSEC source: 0001225208-18-003773 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,675 F1 · kind: Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $69.95 to $70.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:32 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 3,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003320 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,248 F1 · kind: Restricted stock unit award granted under the issuer's incentive compensation plan. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 16:57 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-18-000034 · edgar.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,764 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:48 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Tax withholdingCommon Stock | 272 | $73.20 | $19,910.40 |
DisclosureSEC source: 0001225208-17-018489 · doc4.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,143 F1 · kind: Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding. Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 16:42 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000231 · edgar.xml · nonDerivative · entry 1 Verduin Patricia · CIK 0001290501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,743 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 16:51 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 49,069 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015314 · doc4.xml · derivative · entry 1 Verduin Patricia · CIK 0001290501 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,069 Underlying: Common Stock · 49,069 shares Expires 2023-09-25 F1 · kind: Stock option award granted under the issuer's incentive compensation plan. F2 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 25, 2017 grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.